CUMBERLAND PHARMACEUTICALS
CPIX · NASDAQ
更新於 2026-10-13 13:02:02
----
- 今日最高
- --
- 今日最低
- --
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
...
K線圖趨勢，實際資料以交易頁為準
關鍵數據
- 昨天開盤價
- $6.66
- 昨天收盤價
- $7.00
- 成交量
- 11.54K
- 市值
- $104.88M
- 市盈率（P/E）
- --
- 每股收益（EPS）
- $-0.72
昨天價格區間
$6.66$7.24
52週價格區間
$1.85$9.27
公司概況
- 板塊
- 醫療保健
- 行業
- 製藥
- 子行業
- 藥品製造商 - 專科及仿製藥
- 總部
- 1600 WEST END AVENUE, NASHVILLE, TN, UNITED STATES, 37203
- 國家
- 美國
- 上市日期
- 2009-08-11
- 財年截止
- 十二月
- 流通股數
- 14.98M
- CIK
- 0001087294
Cumberland Pharmaceuticals Inc. 是一家專科製藥公司，專注於在美國及國際間收購、開發及營銷用於醫院急性護理、胃腸病學及風濕病的處方產品。公司總部位於田納西州納什維爾。
財務指標
營業收入
2026-06-30
$166.45K
2026-03-31
$9.13M
2025-12-31
$13.67M
2025-09-30
$8.29M
營業支出
2026-06-30
$3.28M
2026-03-31
$10.32M
2025-12-31
$12.8M
2025-09-30
$9.26M
淨利潤
2026-06-30
-$4.11M
2026-03-31
-$3.13M
2025-12-31
-$1.41M
2025-09-30
-$1.94M
淨利潤率
2026-06-30
-2.47K%
2026-03-31
-34.36%
2025-12-31
-10.32%
2025-09-30
-23.4%
每股收益
2026-06-30
$-0.20
2026-03-31
$-0.21
2025-12-31
$-0.09
2025-09-30
$-0.12
息稅折舊攤銷前利潤
2026-06-30
-$3.12M
2026-03-31
-$1.48M
2025-12-31
$47.84K
2025-09-30
-$510.68K
有效稅率
2026-06-30
-0.12%
2026-03-31
-0.12%
2025-12-31
-1.65%
2025-09-30
-0.29%
| 項目 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| 營業收入 | $166.45K | $9.13M | $13.67M | $8.29M |
| 營業支出 | $3.28M | $10.32M | $12.8M | $9.26M |
| 淨利潤 | -$4.11M | -$3.13M | -$1.41M | -$1.94M |
| 淨利潤率 | -2.47K% | -34.36% | -10.32% | -23.4% |
| 每股收益 | $-0.20 | $-0.21 | $-0.09 | $-0.12 |
| 息稅折舊攤銷前利潤 | -$3.12M | -$1.48M | $47.84K | -$510.68K |
| 有效稅率 | -0.12% | -0.12% | -1.65% | -0.29% |
常見問題
風險提示
股價可能大幅波動，短時間內可能出現顯著漲跌。 數位資產與衍生性商品交易可能涉及槓桿、流動性等額外風險。 本頁內容僅供參考，不構成任何投資建議。 產品可用性與訪問可能因地區及適用法規而異。